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Stephen J Harrop1, John J Hopwood2 and J Mitchell Guss1*
Background: Sulfatases catalyze the hydrolysis of sulfuric acid esters from a wide
variety of substrates including glycosaminoglycans, glycolipids and steroids. There
is sufficient common sequence similarity within the class of sulfatase enzymes to
indicate that they have a common structure. Deficiencies of specific lysosomal
sulfatases that are involved in the degradation of glycosamino-glycans lead to rare
inherited clinical disorders termed mucopolysaccharidoses. In sufferers of multiple
sulfatase deficiency, all sulfatases are inactive because an essential post-
translational modification of a specific active-site cysteine residue to oxo-alanine
does not occur. Studies of this disorder have contributed to location and
characterization of the sulfatase active site. To understand the catalytic mechanism
of sulfatases, and ultimately the determinants of their substrate specificities, we
have determined the structure of N-acetylgalactosamine-4-sulfatase.
Results: The crystal structure of the enzyme has been solved and refined at
2.5 Å resolution using data recorded at both 123K and 273K. The structure has
two domains, the larger of which belongs to the a/b class of proteins and
contains the active site. The enzyme active site in the crystals contains several
hitherto undescribed features. The active-site cysteine residue, Cys91, is found
as the sulfate derivative of the aldehyde species, oxo-alanine. The sulfate is
bound to a previously undetected metal ion, which we have identified as calcium.
The structure of a vanadate-inhibited form of the enzyme has also been solved,
and this structure shows that vanadate has replaced sulfate in the active site and
that the vanadate is covalently linked to the protein. Preliminary data is presented
for crystals soaked in the monosaccharide N-acetylgalactosamine, the structure
of which forms a product complex of the enzyme.
Conclusions: The structure of N-acetylgalactosamine-4-sulfatase reveals that
residues conserved amongst the sulfatase family are involved in stabilizing the
calcium ion and the sulfate ester in the active site. This suggests an archetypal
fold for the family of sulfatases. A catalytic role is proposed for the post-
translationally modified highly conserved cysteine residue. Despite a lack of any
previously detectable sequence similarity to any protein of known structure, the
large sulfatase domain that contains the active site closely resembles that of
alkaline phosphatase: the calcium ion in sulfatase superposes on one of the zinc
ions in alkaline phosphatase and the sulfate ester of Cys91 superposes on the
phosphate ion found in the active site of alkaline phosphatase.
Introduction
Sulfated glycosaminoglycans, glycolipids, glycoproteins and
hydroxysteroids are hydrolyzed by a group of sulfatases,
each of which has exquisite specificity towards its individ-
ual substrate in vivo. A number of sulfatases with very dif-
ferent natural substrates are active in vitro against a common
set of small aromatic substrates, hence the name arylsul-
fatase for some of the enzymes. Eleven different mam-
malian sulfatases have been identified; eight in lysosomes
and three associated with microsomal membranes. To date,
eight inherited human disorders are known to result from
the deficiency of a specific sulfatase. Enzyme-replacement
therapy is a good candidate for the treatment of these disor-
ders. In contrast to the catabolic sulfatases, steroid sulfatase
activity is essential for the synthesis of oestrogens and other
steroids; the steroid sulfatases are drug design targets for the
treatment of breast or endometrial cancers. Sequence con-
servation in the sulfatase family is only about 20–30% for
any pair of enzymes, but is nevertheless sufficient to indi-
cate that members of the family share a common structure. 
A recent observation [1] shed light on the location and
nature of the active site in all sulfatases. Multiple sulfatase
deficiency (MSD) is a rare inherited disorder, in which all
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known sulfatases are catalytically inactive. In MSD cells,
the cause of the disorder has been identified as the failure
to post-translationally modify a specific cysteine residue to
2-amino-3-oxopropanoic acid (oxo-alanine) in arylsulfatase
A (ASA) and in N-acetylgalactosamine-4-sulfatase (4-S,
EC 3.1.6.12, first termed arylsulfatase B before its in vivo
substrate was discovered). The equivalent of this cysteine
residue is conserved in all mammalian sulfatases.
The glycosylated, lysosomal enzyme 4-S removes the sulfate
ester group from position 4 of an N-acetylgalactosamine sugar
at the non-reducing terminus of the polysaccharide in the
degradative pathways of the glycosaminoglycans dermatan
sulfate and chondroitin-4-sulfate. The structure of 4-S is
therefore of particular interest in defining the enzyme mech-
anism (the first for any sulfatase), the targeting of the 4-S
enzyme to the lysosome and the stability of the enzyme in
the hostile environment of the lysosome. Besides being one
of many sulfatases deficient in MSD, a specific deficiency in
4-S is responsible for the pathogenesis of Maroteaux–Lamy
syndrome  or mucopolysaccharidosis (MPS) type VI. This
autosomal recessive disorder of glycosaminoglycan catabo-
lism leads to storage and excretion of excessive amounts of
dermatan sulfate and chondroitin 4-sulfate. It presents with a
variety of clinical phenotypes, but in its severest form results
in dwarfism, gross skeletal changes and cloudy corneas
without mental deterioration [2]. MPS VI is a good candidate
for enzyme-replacement therapy for a number of reasons:
firstly, only a small quantity of enzyme needs to be delivered
to the target cells to reverse the morphological changes; sec-
ondly, there are a number of animal models for the disease;
thirdly, there is no central nervous system involvement that
would require the enzyme to cross the blood–brain barrier;
and lastly, the enzyme is sufficiently stable to reach the
target cells. Recombinant human enzyme is currently being
produced [3] and tested in animals with a view to human
trials in the near future.
We report the crystal structure of 4-S at a resolution of
2.5Å refined at both 123K and 293K. We also report the
structure, at 2.8 Å resolution, from crystals soaked in meta-
vanadate, a potent inhibitor of the enzyme. Given the sig-
nificant sequence homology in the sulfatase family of
enzymes (Fig. 1), including steroid sulfatase, we conclude
that the structures of all sulfatases will share the important
features found in the structure of 4-S.
Results and discussion
Molecular structure
The structure of 4-S is a monomer with two domains, as shown
in Figure 2. The larger, N-terminal domain has a/b topology
with a 10-stranded mixed b sheet flanked by two long closely
packed a helices on one side and a number of shorter a helices
on the other (Fig. 2). The overall twist in the large b sheet 
is 105°, but 75° of that is accounted for by the two edge strands
(j and f). The twist for the central eight stands of the sheet is
quite small, with an average of only 4° per strand. The curva-
ture of the sheet is negligible. The smaller, C-terminal domain
consists of a four-stranded antiparallel b sheet with an orthogo-
nal a helix on the solvent-exposed side (Fig. 2). The carboxyl
end of the small domain continues into a long ribbon that
crosses the molecule, entering a single turn of a helix which is
linked by a disulfide bridge to the large domain near to strand
e of the large b sheet. 
A significant structural homology between the large domain
of 4-S and alkaline phosphatase [4] (ALK; PDB acces-
sion code 1ALK) (Fig. 3) was identified using DALI [5], a
procedure that recognizes common structural motifs. An
optimized least-squares superposition of 169 structurally
homologous Ca atoms yields a root mean square (rms) devi-
ation of 1.9Å [6]. These structurally equivalent residues in
ALK are included in the sequence alignment in Figure 1.
As only 27 of the structurally equivalent 169 residues are
also identical in 4-S and ALK, it is not surprising that no
overall sequence homology is recognizable between the two
proteins when the full-length peptides are used in the com-
parison. The overall topology of the large b sheet is nearly
identical in the two proteins. In ALK, the two edge strands f
and e (Fig. 2a) are reversed in order compared with 4-S, and
both are parallel to strands d–h. Thus, ALK has a contigu-
ous stretch of seven parallel strands in the sheet, whereas
4-S has only five contiguous parallel strands.
The active site
The active site of 4-S was readily located by the presence
of a cluster of conserved residues surrounding the post-
translationally modified essential cysteine residue (Cys91)
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Figure 1 continued
Alignment of the amino acid sequences of the human sulfatase enzymes:
N-acetylgalactosamine-4-sulfatase (4-S), galactose-3-sulfatase(ASA),
N-acetylgalactosamine-6-sulfatase(GAL6S), steroid sulfatase (STS) and
N-acetylglucosamine-6-sulfatase(GLU6S). Residues identical in at least
four of the five sulfatases are highlighted in red, with conservatively
substituted residues highlighted in yellow. The secondary structure
assignments and sequence numbering for the 4-S structure are
indicated. Cylinders represent a helices and arrows represent b sheets.
The colouring of secondary structure elements is given in the caption to
Figure 2. Green triangles: metal ligand residues in 4-S. Up-pointing black
triangle: modified cysteine. Left-pointing solid black triangles: proteolytic
clipping sites in 4-S. Left-pointing open triangle: N-terminal leader
sequence in 4-S. Grey highlight: unmodelled disordered region in 4-S.
The sequence for the 169 residues of alkaline phosphatase (ALK) that
are structurally equivalent to 4-S is given at the bottom. Residues
identical in ALK and 4-S after structural alignment are highlighted in blue;
the blue circles indicate metal ligands to the Zn2+ spatially equivalent to
the Ca2+ in 4-S. This figure was prepared with ALSCRIPT [38].
[1]. Two site-directed changes (Cys91→Ser and Cys91→
Thr), which have been shown to destroy enzyme activity
[7], emphasize the identity of Cys91 as the essential cys-
teine residue. The sulfatase catalytic site lies in a cleft on
the surface of the enzyme (Fig. 4), at the carboxyl end of
the central parallel portion of the b sheet, at a position
where the direction of the strands reverses (Fig. 2b,c).
This location for the active site is often observed in the
a/b family of enzymes [8] and is also found in ALK. The
conserved residues that line the active-site pocket are
Asp53, Asp54, Cys91, Pro93, Ser94, Arg95, Lys145, His147,
His242, Asp300 and Lys318 (Fig. 5).
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Figure 2
Topology and structure of 4-S. Colours
represent: yellow, b strands large domain;
red, other elements of the large domain; cyan,
b strands small domain; blue, other elements
of the small domain; green, the b hairpin
identified as a possible recognition element
for targeting to the lysosome; grey, a flexible
loop not visible in the electron-density maps.
Molecular drawings were made with
MOLSCRIPT [39] and RASTER3D [40,41].
(a) Topological diagram of the polypeptide
fold of 4-S with b pleated sheets indicated by
arrows and a helices by cylinders. (b) The
molecular structure of 4-S. The larger
N-terminal domain is in the lower part of the
figure with the smaller C-terminal domain in
the upper left corner. The modified residue,
Cys91, at the active site is drawn with a ball-
and-stick representation. The putative
b-hairpin recognition element points vertically
up on the right of the picture. (c) View of the
molecule rotated 90° from the view in (b).
(d) Stereoview of a Ca trace of the molecule;
every twentieth Ca atom is labelled with the
residue number.
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The post-translational modification and metal-binding site
A metal ion and the essential cysteine residue, Cys91, are
located at the base of the substrate-binding pocket (Fig. 5).
The cysteine is part of a highly conserved linear sequence
in the sulfatase family of enzymes (Fig. 1), which has been
proposed to act as a recognition element for the enzyme
that makes the modification [7]. This sequence similarity
does not extend to ALK, in which this cysteine residue is
absent and no post-translational modification takes place
(Fig. 1). It has been proposed by von Figura and colleagues
[1], that this cysteine residue in sulfatases undergoes a con-
version to oxo-alanine and that the free aldehyde function
is stabilized as an enol or linked to an amino or a hydroxyl
group of the polypeptide forming a Schiff’s base or a hemi-
acetal. They showed that this residue has an aldehyde
group by reduction of the enzyme with sodium borohy-
dride under conditions specific for aldehyde reduction, and
identification of a resultant serine residue in the sequence
in place of the encoded cysteine. Roy and Mantle [9] have
demonstrated the sulfate-induced modification of arylsul-
fatases by observing a loss of activity on the binding of
35SO42–, but attempts to isolate and identify the modified
residue were unsuccessful. 
Examination of the electron density in both the multiple
isomorphous replacement (MIR) and difference electron-
density maps in the region of residue 91 revealed a large
positive peak, located approximately 1.5Å from the puta-
tive position of the aldehyde oxygen in oxo-alanine (Fig. 6).
This peak was about 50% larger than the difference elec-
tron density features later identified as well ordered water
molecules. A second peak, the size of a water molecule, was
located approximately 1.2Å from the putative Cb atom of
the sidechain. The large peak in the region of Cys91 was
modelled as a sulfur atom and the smaller one as oxygen.
Continued refinement and difference electron-density
maps then indicated the presence of three more oxygen-
sized atoms bonded to the putative sulfur atom. These
observations are consistent with a model in which Cys91
has been modified to the sulfate ester of a hemiacetal of
oxo-alanine (Fig. 7). The sulfate ester is favoured over the
alternate possibility of an anhydride derivative of a car-
boxylic acid by the apparent tetrahedral bonding around the
Cb atom of the sidechain. This is suggested in the MIR and
omit electron-density maps, which indicate the presence of
an unseen hydrogen atom, and by the chemical identifica-
tion of the parent compound as an aldehyde and not a car-
boxylic acid as discussed earlier. We note that this X-ray
experiment in itself cannot distinguish between a phospho-
rus atom and a sulfur atom and that phosphate present
during the isolation of the protein may be incorporated into
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Figure 3
Superposition of the central part of the large ab domain of 4-S (yellow
and red) and the structurally equivalent part of alkaline phosphatase
(cyan and blue). The green and magenta spheres represent the sulfate
and phosphate ions, respectively, and the grey and black spheres the
Ca2+ and Zn2+, respectively.
Figure 4
Molecular surface coloured according to the electrostatic potential
using GRASP [42], where red represents negative charges and blue
positive charges. A stick representation of a tetrasaccharide modelled
into the active site is superimposed; atoms are shown in standard
colours. The oligosaccharide is seen emerging from the active-site
cleft, the base of which is positive due to the basic residues that bind
the sulfate.
the crystals. Alternatively, the initial post-translational form
of 4-S may have a phosphate ester at the oxo-alanine alde-
hyde residue and this phosphate ester may be replaced with
a sulfate following the first catalytic reaction of 4-S with 
a sulfate ester substrate. One of the terminal oxygen atoms
of the sulfate makes hydrogen-bonded contacts with the
sidechains of His242 and Lys318, and with the peptide
nitrogen of residue 91 (Fig. 5a,b). The hemiacetal is further
stabilized by hydrogen bonds from the free hydroxyl
oxygen atom to Arg95, His147 and Lys145. In Figure 5b,
the proton is shown on His147, which is consistent with a
pH of 5.1 in the crystal buffer. Two of the sulfate oxygen
atoms are ligands to the metal ion (see below). The sulfate
ester observed in the crystals could be formed simply by
the addition of sulfate to the aldehyde resulting from 
the modification of Cys91. The recombinant enzyme is,
however, fully active [10], and early formation of the sulfate
ester would protect the very reactive oxo-alanine.
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Figure 5
The active site in 4-S. (a) Stereoview showing
Asp53, Asp54, residue 91, Arg95, Lys145,
His147, His242, Asp300, Asn301, Lys318
and the metal ion. Acid sidechains are in red
and basic sidechains in blue. Residue 91 is
shown in green with the sulfate and oxygen
atoms as yellow and red, respectively.
(b) Sketch view of the catalytic site showing
the hydrogen-bonded interactions (dashed
lines) that stabilize the sulfate ester. The
seven coordinate metal ion is on the left. A
salt-bridge interaction between Lys145 and
the O (carboxyl) atom of Asp53, which is not
coordinated to the metal ion, and a number of
charges and double bonds are omitted from
the figure for clarity. 
(b)
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The peptide bond between Ser240 and Val241, adjacent
to the active-site His242, has been modelled in the cis
configuration. Extensive checks with unbiased omit elec-
tron-density maps (Fig. 6c) support the assignment of 
this unusual, but not unprecedented [11], non-proline cis-
peptide. Such non-proline cis-peptides are often observed
in the active sites of enzymes [12,13], where they presum-
ably achieve the essential constraints for substrate binding
and catalysis. 
Structure of an inhibitor complex
Further evidence for the identity of the cysteine residue
involved in post-translational modification and the loca-
tion of the active site is provided by the structure obtained
by soaking crystals of 4-S in sodium metavanadate
(Table 1). Vanadate has been shown to be a potent
inhibitor of human placental steroid sulfatase [14], Helix
pomatia aryl sulfatase [15] and human 4-S (PRC, unpub-
lished results). The observed inhibition was of an order
consistent with vanadate acting as a transition-state ana-
logue. The only change in the structure is the apparent
replacement of sulfate by vanadate (Fig. 6b). The limited
resolution of the vanadate data does not permit a dis-
tinction between tetrahedral VO4 and trigonal bipyrami-
dal VO5. The latter, which would be the transition-state
analogue, is shown modelled into omit electron density in
Figure 6b.
The metal-binding site
A large peak first observed in a difference electron-density
map close to the covalently linked sulfate ion is most accu-
rately modelled as a calcium ion. The chemical identity of
the metal ion was tested by successive temperature para-
meter refinements. The results, Mg2+ ≤2Å2; Ca2+ =25Å2;
Mn2+ =34Å2; and Zn2+ =43Å2, show that the value for Ca2+
is closest to the temperature factors of the coordinating
atoms. The metal ion is coordinated by seven atoms from
the sidechains of Asp53 Od1, Asp54 Od2, Asp300 Od1 and
Od2, Asn301 Od1 and two of the sulfate oxygen atoms
(Fig. 5a,b). The lengths of the metal-ligand bonds (2.3 to
2.6Å), the coordination geometry and the presence of
three, or possibly four, negatively charged groups are con-
sistent with the X-ray assignment of Ca2+. The conserva-
tion of the metal-coordinating groups in the sulfatase
family (Fig. 1) suggests that all sulfatases require the pres-
ence of a metal ion. We propose that the role of the metal
ion is to stabilize the formation of the sulfate ester, but 
it cannot be assumed that the ion is Ca2+ in vivo, as 
the purification and crystallization of the enzyme may
have caused the endogenous ion to be replaced. While a
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Figure 6
Omit and difference electron-density maps.
Prior to the calculation of omit maps, the
models were subjected to simulated annealing
with the atoms omitted from structure factor
calculations to minimize model bias. (a) Omit
map calculated omitting contributions from
the sidechain atoms of residue 91, the metal
ion and water molecules in the active site
(2.5 Å resolution, green lines: 3.25s
contours). (b) Omit map calculated with
contributions from the vanadate ion omitted
(2.5 Å resolution, green lines: 3.25s
contours). Difference electron-density map
(2.8 Å resolution, light blue lines: 9.0s
contours) calculated with amplitudes
|Fo,v–Fo,N|, where Fo,v are the observed
amplitudes for the vanadate-soaked crystals
and Fo,N are the amplitudes from the native
crystals at room temperature and phases from
the refined model calculated omitting the
vanadate. The pentavalent vanadate is shown
in ball-and-stick representation. The black
stick lines represent the sulfur–oxygen bonds
in the sulfate ester. (c) Omit map calculated
omitting contributions from residues 240 to
241 (2.5 Å resolution; green lines, 4.0s
contours). (d) Difference electron-density map
(3.3 Å; resolution, green lines, 1.5s contours)
calculated with amplitudes |Fo–Fc|, where Fo
are the observed amplitudes for the GalNAc-
soaked crystals and Fc are the calculated
structure factors from the refined model at
room temperature . The model of GalNAc has
been fitted to the electron density without
refinement. The hydroxyl on the 4 position of
the sugar ring has been placed within bonding
distance of the sulfur atom of residue 91.
Atoms and bonds are coloured as follows:
carbon, yellow; nitrogen, blue; oxygen, red;
sulfur, green; calcium, magenta; vanadium,
yellow; GalNAc, black.
pH-dependent requirement for a divalent metal ion, 
Cu2+ or Zn2+, and enzyme inactivation with EDTA have
both been demonstrated for glucuronate-2-sulfatase [16],
steroid sulfatase was not inactivated in the presence of
EDTA [14].
The superposition of the central part of the large domain
of 4-S and ALK (above) also superposes the active sites of
the two enzymes. The Ca2+ in 4-S is less than 1Å from the
position of a Zn2+, one of the three metal ions in ALK
(Fig. 3). Two of the aspartate ligands of the Zn2+ in ALK
are conserved in sulfatases and are Ca2+ ligands in 4-S
(Fig. 1). Furthermore, the sulfate ion in 4-S superimposes
on the position of a phosphate ion found in the active site
of ALK (Fig. 3).
The enzyme mechanism
On the basis of the assumption that the sulfate ester is the
resting form of the enzyme, we can envisage the following
reaction scheme. The covalently linked sulfate may either
be released by hydrolysis involving a nucleophilic attack,
possibly by water as has been proposed for the mechanism
of alkaline phosphatase [4], or it may be only relatively
weakly bound to the enzyme and could be in equilibrium
with the free aldehyde form. Given that the substrate and
products have to enter and exit from the active site in 
the same direction, it is very unlikely that the negatively
charged substrate and the covalently bound sulfate are
present in the active site simultaneously. In the next 
step, the glycosaminoglycan then binds to the enzyme, and
the 4-sulfate group of the galactosamine residue forms a
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Table 1
Data collection and MIR phasing statistics.
Data set Resolution Observations Unique Completeness Rsym* Rscale† Phasing 
(Å) reflections (%) (%) (%) power‡
N123 (native at 123K) 2.5 194 673 27 332 91.9 8.9 - -
N273 (native at 273K) 2.5 49 299 25 091 85.0 7.0 - -
NVO3 (vanadate) 2.8 32 946 15 186 90.4 5.7 8.3 -
PIP 3.5 15 030 8525 78.0 8.0 17.4 2.79
cis-Platin 4.0 4901 4231 57.4 8.6 15.8 0.74
HgOAc 3.0 19 073 11 045 62.9 10.8 16.3 0.60
*Rsym = Σ | Ih – < Ih > | / Σ Ih, where < Ih > is the average intensity over symmetry equivalents. †Rscale = Σ |FPH – FH | / Σ |FP |. ‡Phasing
power = Σ |FH | / Σ ||FPHobs | – | FPHcalc ||.
Figure 7
Scheme for the post-translational modification
of the essential active-site cysteine residue.
The scheme is adapted from the proposal of
von Figura and colleagues [1], with the
addition of the final step of the reaction that
shows the formation of the sulfate ester.
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covalent ester bond to residue 91. A nucleophile such as
water, another residue of the protein, or a hydroxyl group of
the substrate attacks the sulfur atom, making a 5-coordinate
intermediate stabilized by the metal ion. This intermedi-
ate then collapses, breaking the bond between the sulfur
and the glycosidic oxygen, releasing the glycosaminoglycan
and leaving the sulfate bound to residue 91. This scheme is
consistent with the formation of the enzyme–sulfate
complex being the last intermediate in the catalytic cycle,
as proposed by Roy and Mantle [9]. A concerted mecha-
nism such as that proposed by O’Fagain et al. [17] is also
possible, and may be more likely to occur with the natural
substrate that does not exhibit the anomalous kinetics
observed with some arylsulfate substrates [9]. The sulfate
ester form of 4-S that we have found in our crystals is
equivalent to the phosphoserine intermediate proposed for
the reaction mechanism of alkaline phosphatase [4]. We
also note that, in the catalysis of phosphatidylinositol-
4,5-bisphosphate by a phosphoinositide-specific phospholi-
pase C [18], the sugar C2 hydroxyl, which also coordinates
calcium, is proposed to act as the nucleophile.
Given the overall similarity of the structures and proposed
reaction mechanisms of 4-S and alkaline phosphatase, it is
reasonable to ask whether or not 4-S has phosphatase
activity, especially at a pH higher than its optimum for
sulfatase activity, at which point the difference in pKa of
the sulfate and phosphate ions might favour one reaction
over the other. The enzyme does have an extremely small,
but measurable, activity towards 4-methylumbelliferyl-
phosphate equal to 0.01% of the activity towards 4-methy-
lumbelliferyl-sulfate in a pH range of 3.5–6.5. Equally,
however, this trace amount of phosphatase activity may
have resulted from a phosphatase impurity. We have indi-
cated above that the ester we see in the crystals may well
be phosphate, even at low pH.
In the absence of the structure of a substrate–enzyme
complex for 4-S, the elements responsible for its substrate
specificity are not clearly defined. The binding site has
been mapped using a combination of search probes with
the computer program GRID [19]. This calculation locates
the sugar residue at the reducing terminus of the oligosac-
charide, in one of two orientations related by an approx-
imately 180° rotation about the C(1)–C(4) bond of the
N-acetylgalactosamine ring, which roughly parallels the
direction of a chondroitin-4-sulfate polysaccharide chain.
Experimental evidence in support of this calculation is
provided by the structure of crystals of 4-S soaked in
100mM N-acetylgalactosamine (GalNAc). The high con-
centration of GalNAc was required because the binding of
monosaccharides to 4-S is known to be weak (Ki =2.8mM;
PRC, unpublished results). An electron-density difference
map shows density for the GalNAc next to the sulfate on
the open side of the binding pocket (Fig. 6d). The limited
resolution and incomplete data make it impossible to
accurately fix the position and orientation of the mono-
saccharide, but it is not incom-patible with a product-
like complex in which the sugar-to-sulfate bond has just
been cleaved.
In a true substrate complex, the sulfate in position 4 of the
substrate would be fixed by its covalent bond to residue
91 via the sulfate ester link. We have modelled such a
complex with a tetrasaccharide substrate. In one orienta-
tion, enzyme–substrate contacts, other than to the sulfate,
are made by Pro116, Gly171, Leu170 and Trp319. In 
this model, the next sugar residue of the substrate con-
tacts Trp115, Arg180 and Ser172, and one of two chloride
ions located by structure analysis interacts with the C-6
hydroxyl group of the terminal sugar. Because we cannot
accurately locate any of the above residues except the
non-reducing terminal sugar, our model does not explain
why the hydrolysis of trisaccharide and pentasaccharide
substrates is more efficient than that observed for mono-
and disaccharides [20]. This latter observation implies that
there should be an extensive binding site on the surface of
the protein. Within extended substrates, the aglycone fea-
tures that have been shown to be important are a uronic
acid C-6 carboxyl group and a second 4-sulfated GalNAc
residue. The structural analysis of an oligosaccharide-sub-
strate–enzyme complex is required before we can resolve
these issues. 
Glycosylation and lysosomal processing
There are five consensus N-linked carbohydrate sites in
4-S (Fig. 8). All these sites are on the surface of the
protein and are readily accessible to solvent. In unbiased
electron-density maps, we see clear evidence for glycosy-
lation at Asn279 (Fig. 9) and Asn426; there is also a disor-
dered carbohydrate at Asn366, but no electron density
indicating glycosylation at the other sites. A disaccharide
of b(1→4) linked N-acetylglucosamine residues has been
included at each of the two occupied sites in the current
model. Absence of electron density does not, of course,
prove that these additional sites are not glycosylated. The
mass of the polypeptide, calculated from the sequence
(residues 38–533), is 56kDa, compared with 66kDa calcu-
lated by electrophoresis or mass spectrometry. The differ-
ence, 10kDa, would be compatible with occupation of as
many as five carbohydrate-binding sites.
Processing of the precursor 4-S protein to the mature form
involves proteolytic cleavage on the C-terminal side of
residues 423 and 465 (Fig. 8) [21]. In the crystal structure
of 4-S, the loop from residues 407 to 422, which is anchored
at one end by a disulfide bridge (Cys405– Cys447) and ter-
minates at one of the cleavage sites, is not readily visible in
the electron density. Although there is up to 20% of the
mature form of the protein in the crystals, the invisibility of
this loop is probably due to its flexibility in both the pre-
cursor and mature forms of the enzyme, since the loop
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would be visible if it were ordered only in the precursor
form. The second proteolytic-clipping site is on an exposed
corner of the long loop joining the third and fourth strands
of the b sheet in the smaller domain. The four disulfide
links (Fig. 8) are able to maintain the tertiary structure
after proteolytic cleavage.
Lysosomal targeting
From mutational studies on cathepsin D [22,23] and recent
structural work on human b-glucuronidase [24], a consen-
sus motif that targets these enzymes to the lysosome has
been suggested. This motif is described as an extended
b hairpin. The only comparable feature in 4-S is the loop
between residues 178 and 195 (Fig. 2) — a b-hairpin excur-
sion between strands d and e of the main sheet, the base of
which is pinned by a disulfide bridge. We find no sequence
similarity between this loop and the corresponding loops in
cathepsins B and D or b-glucuronidase. Furthermore, this
is a highly variable region of the sulfatase enzymes (Fig. 1),
which suggests that a structural motif rather than a specific
sequence is required for lysosomal targeting. The exposed
location of the hairpin feature would enable it to be bound
by the targeting enzyme, N-acetylglucosamine 1-phospho-
transferase. A potential N-glycosylation site is present on
the exposed end of this hairpin loop.
Mutations of 4-S in Maroteaux–Lamy patients
Sixteen single site mutations in 4-S have been identified 
in Maroteaux-Lamy syndrome patients: T92M, R95Q,
C117R, G137V, G144R, R152W, R160Q, C192R, Y210C,
L236P, L321P, H393P, C405Y, L498P, C521Y and ter534Q
(using the single letter amino acid code; ter denotes a ter-
mination codon) [25–29]. Of these mutations, only R95Q is
in the active site and it has been shown virtually to elimi-
nate 4-S activity [25]. A number of these mutations are
likely to have structural consequences for the folding of the
protein. Gly137 and Gly144 are highly conserved in all
mammalian sulfatases, and their observed backbone tor-
sional angles (f and ϕ; 92.8°, 17.5°; and 124.3°, –153.3°;
respectively) are rarely observed for non-glycine residues.
Each of the four cysteine residues, for which deleterious
mutations have been observed, form disulfide bonds which
are important for the stability of the mature form of the
enzyme (Fig. 8).
Biological implications
Sulfatase enzymes catalyze the hydrolysis of sulfuric acid
esters on the pathways for the catabolism of glycosamino-
glycans and glycolipids and in the synthesis of steroid hor-
mones. Sequence similarity within the sulfatase family
suggests that members have a common structural fold
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Figure 8
Schematic diagram of the 4-S peptide
showing the location of the disulfide bridges
(S–S), proteolytic clipping sites (gaps in the
polypeptide) in the mature form of the enzyme
and the five consensus N-linked glycosylation
positions (CHO; red indicates that sugar
residues are included in the model at this
site).
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Figure 9
Attached carbohydrate structure in 4-S. View of the solvent-flattened
MIR electron-density map (1.3s contour). The refined model including
a disaccharide of two N-acetylglucosamine sugar residues (ball-and-
stick representation) is shown fitted into the electron density. The
sidechains of the polypeptide have been omitted for clarity. Atom
colours are as in Figure 6. 
and position of the active site. Deficiency of any one of 
the catabolic enzymes typically leads to a rare inherited
disorder, which in turn results in lysosmal accumulation
of metabolic products. Deficiency of N-acetylgalac-
tosamine-4-sulfatase (4-S), which normally degrades der-
matan sulfate and chondroitin sulfate, leads to the clinical
condition mucopolysaccharidosis type VI or Maroteaux–
Lamy syndrome; whereas inhibitors of steroid sulfatases
may be used to regulate the synthesis of oestrogens and
may contribute to the treatment of breast or of endome-
trial cancers.
The crystal structure of 4-S shows that the enzyme has
two domains, with the active site at the base of a cleft on
the larger domain. A cysteine residue that had been iden-
tified previously as the position of a post-translational
modification essential for the activity of all sulfatases is
located in the active site. The modification was identified
by a comparison of normal sulfatases with those isolated
from cultured cells obtained from patients with multiple
sulfatase deficiency. Chemical structure analysis showed
that the modification was the conversion of the cysteine
to an aldehyde, oxo-alanine (2-amino-3-oxopropanoic
acid). In our crystals, the inherently unstable oxo-alanine
is found as the sulfate derivative of the aldehyde. Previ-
ous work showing that sulfate is both required for
enzyme activation and acts as an inhibitor of 4-S is ratio-
nalized by a reaction scheme, which requires the dis-
placement of covalently bound sulfate by the substrate
polysaccharide sulfate group prior to cleavage of the
sulfate from the substrate by an unknown nucleophile,
that may prove to be water.
The active site was also found to contain a metal ion
that has not previously been implicated in the mecha-
nism of 4-S. The metal ion has been identified crystallo-
graphically and from its coordination geometry as Ca2+.
The protein residues that stabilize the sulfate ester and
that bind the calcium ion are conserved throughout the
family of sulfatase enzymes, suggesting that these are
common features. The structure of crystals soaked in
metavanadate, a known potent inhibitor of the enzyme,
shows that vanadate displaces the covalently bound
sulfate and binds covalently in its place. The bulk of the
polysaccharide substrate will bind on the open side of
the active site, as indicated by a low-resolution structure
of a monosaccharide bound to the enzyme. The sub-
strate specificity will no doubt be conferred by residues
lining the cavity, but their nature awaits a high-resolu-
tion structure of a substrate analogue–enzyme complex.
The fold of the large domain in 4-S closely resembles 
that of alkaline phosphatase, despite a lack of apparent
sequence identity prior to the structure determination of 4-
S. The similarity may not be all that surprising in retro-
spect, given the similar nature of the chemical reactions
catalyzed by the two enzymes. Alkaline phosphatase has
three metals, two Zn2+ and one Mg2+, in its active site. One
of the zinc ions superimposes almost exactly on the calcium
ion in 4-S, and a phosphate ion in alkaline phosphatase
superimposes on the covalently bound sulfate in 4-S.
The structure of 4-S has provided details of the essential
post-translational modification of the enzyme and sug-
gested a plausible enzyme mechanism. Other features of
the structure suggest that the enzyme may be recognised
for targeting to the lysosome by a hairpin-loop motif
rather than a specific sequence. The structure reveals
disulfide bonds that may stabilize 4-S in the presence of
proteases, which cleave it at two positions. The struc-
ture is archetypal for the family of sulfatases and may,
in the absence of a structure for steroid sulfatase, be
useful in the design of steroid sulfatase inhibitors.
Materials and methods
Crystallization and data collection
Recombinant human 4-S is being produced in large quantities in
Chinese hamster ovary (CHO) cells with a view to its use in enzyme-
replacement therapy. The recombinant enzyme is glycosylated but lacks
the N-terminal 38-residue peptide that is lost on entering the endoplas-
mic reticulum. This precursor enzyme, of 66kDa, is clipped at two places
by unidentified proteases in the late endosome or lysosome compart-
ments to yield the mature form, comprising three polypeptides linked by
interchain disulfide bonds (Fig. 8) [21]. It is known that the mature form
will not bind to the cation-independent mannose-6-phosphate receptor,
indicating loss of the mannose-6-phosphate tag (S Byers, personal com-
munication). We used a mixture of the precursor and mature forms to
grow crystals of the enzyme [30], and reducing gels indicate that the
crystals appear to contain approximately the same proportions of the two
forms as the original protein mixture (80% precursor, 20% mature; our
unpublished results). We found that the problems with crystal stability
reported earlier [30] could be overcome by growing the crystals in 0.2M
malate/0.1M acetate-buffered solutions at pH5.1. Small changes in
buffer conditions caused non-isomorphism, increasing the difficulty of
obtaining heavy atom derivatives. Crystals grown in the presence of
20% glycerol could be flash-frozen in a stream of cold nitrogen gas.
Data were collected on an R-Axis II imaging plate detector mounted on
an RU-200 rotating anode generator with a Cu target and focussing
mirror optics (Z Otwinowski and G Johnson, Yale University, as mar-
keted by Molecular Structure Corporation, Texas, USA) and using Weis-
senberg geometry cameras fitted with removable image plates on
beamlines 6A2 and 18B at the Photon Factory, Tsukuba Japan [31]. All
data were integrated and scaled with DENZO and SCALEPACK [32].
Native data at 273K were recorded on the R-Axis at a crystal-to-detec-
tor distance of 150 mm using two crystals (space group P41212 with
one molecule per asymmetric unit, a =108.3Å, c =146.2 Å). Native data
at 113 K were recorded on the R-Axis from a single crystal (a =107.0Å,
c=144.8Å) (Table 1).
Phase determination
The structure was solved by multiple isomorphous replacement (MIR)
using three heavy-atom derivatives. Data were recorded on the R-Axis
for mercury acetate and ‘cis-platin’, diaminodichloroplatinum (II), deriva-
tives. Data for a PIP, di-m-iodo bis(ethylene diamine) diplatinum (II)
nitrate, derivative were recorded at the Photon Factory at a wavelength
of 1.0Å (Table 1). In the phasing calculations, the PIP was represented
by two Pt and two I atoms in a planar arrangement. Heavy-atom sites
were derived from RSPS [33] and refined with MLPHARE [33], confirm-
ing the enantiomorph of the space group as P41212 (Table 1). Solvent
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flattening and phase extension by histogram matching using DM [33]
produced an electron-density map at 3.5 Å resolution, with a number of
identifiable features. Map interpretation was aided using secondary-
structure prediction algorithms to assign the segments of the sequence
most likely to form a helices [34]. Approximately 50% of the backbone
and 15% of the sidechains were fitted to this electron-density map with
O [6] and this map was used as a reference in subsequent model-fitting.
‘X-ray sequencing’ of a 30 Å-long a helix identified it as a section bearing
one of the putative glycosylation sites. The MIR map supported this
observation (Fig. 9), with clear density for the oligosaccharide. Repeated
cycles of phase combination between the original MIR phases and
phases calculated from the partial model using SIGMAA [33], followed
by solvent flattening, eventually allowed the tracing of the entire polypep-
tide chain with the exception of a 19-residue surface loop and three
residues at the N terminus. This model was then used as the starting
point of the crystallographic refinement.
Model building and crystallographic refinement
The model was refined with X-PLOR [35], using simulated annealing,
against the native amplitudes recorded at 273K. The standard geometric
parameters for the amino acids were taken from the compilation of Engh
and Huber [36]. Solvent molecules, cations and anions were included if
they had suitable stereochemistry following examination of difference
electron-density maps. Refinement was then reinitiated with a model
containing only the polypeptide against the data recorded at 123K from
flash-frozen crystals at a resolution of 2.5Å. Individual B factors were
refined with strong restraints between bonded and bond-angle related
atoms. The model derived from the low-temperature refinement com-
prises 3818 protein atoms, 270 water molecules, a calcium ion, two
chloride ions and 56 atoms of sugar residues. Residue 91 has been
modelled as a sulfate ester of the hemiacetal form of oxo-alanine as
described in the text. This is the model which has been deposited with
the Brookhaven Protein Data Bank.
Structure of an inhibitor complex
Crystals were soaked for 24 h with sodium metavanadate (0.1 mM, final
concentration) added to the hanging drop in which the crystals had
been grown. Data were recorded on the R-Axis from one crystal at
293K (Table 1). A difference Fourier synthesis using the native ampli-
tudes (room temperature) and the vanadate data with calculated
phases from the refined 273K native model showed a significant peak
close to the position of the sulfur atom of the proposed covalently
linked sulfate (Fig. 6b). This model, omitting solvent, oligosaccharide
and ions, was refined with a vanadium atom replacing the sulfur of
residue 91. The terminal oxygen atoms of the vanadate were assigned
zero occupancy so as not to bias the model to a particular stereochem-
istry around the vanadium. An omit map excluding contributions to the
calculated structure factors from residue 91 is shown in Figure 6b and
the final refinement statistics are shown in Table 2.
Structure of a product complex
Crystals of 4-S were transferred to a stabilizing solution (0.2 M malate/
0.1M acetate, pH5.1, 18% PEG 8K and 10 mM N-acetylgalactosamine)
for 3 days, after which time the GalNAc concentration was increased to
100mM and the crystals were soaked for a further 24 h. Data were
recorded from three crystals with the R-Axis at 293K. The final data set,
which comprises 100% of the reflections measurable to a resolution of
3.3Å, has 13519 unique reflections from 30861 observations with an
Rsym of 9.5%.
Assays for phosphatase and sulfatase activity
Assays were conducted as described using 4-methylumbelliferyl-phos-
phate [37] and 4-methylumbelliferyl-sulfate [10] as substrates over a
range of pH values.
Accession number
The atomic coordinates and the structure factor amplitudes for the
structure refined at 123K have been deposited with the Brookhaven
Protein Data Bank (accession number 1FSU).
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